14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CTRV
Delisted

ContraVir Pharmaceuticals Inc Stock Predictions

$1.23
+0 (+0%)
At Close: May 27, 2022
Currently predicting for Mon, 6 May 2024

CTRV Predictions History

7 years ago
JuanC Villegas predicted that CTRV for 2017-05-02 is going $0.81 (-99.83%)

7 years ago
JS predicted that CTRV for 2017-04-26 is going $1.00 (-99.78%)

7 years ago
JuanC Villegas predicted that CTRV for 2017-04-26 is going $0.760 (-99.84%)

7 years ago
Robert.Laverty.4670 predicted that CTRV for 2017-04-26 is going $1.81 (-99.62%)

Rank:

7 years ago
JS predicted that CTRV for 2017-04-25 is going $1.23 (-99.74%)

7 years ago
Sean predicted that CTRV for 2017-04-25 is going $0.96 (-99.85%)

Rank:

7 years ago
Ryan predicted that CTRV for 2017-04-25 is going $0.83 (-99.87%)

Rank:

7 years ago
JuanC Villegas predicted that CTRV for 2017-04-25 is going $1.45 (-99.78%)

7 years ago
JS predicted that CTRV for 2017-04-07 is going $1.55 (-99.83%)

7 years ago
Jack.Cesario.Migueis.3576 predicted that CTRV for 2017-04-07 is going $1.55 (-99.82%)

Click to get the best stock tips daily for free!

About ContraVir Pharmaceuticals Inc

ContraVir Pharmaceuticals ContraVir Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development of antiviral drugs with a primary emphasis on the treatment of Hepatitis B virus (HBV) infections. The company is developing CMX157 and CRV431 to treat HBV infection; and FV-100, an orally available, small molecule compound for the prevention of post-herpetic neuralgia, and treatment of herpes zoster infection and acute zoster-associated pain. Contr... CTRV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT